Preferred Pharmaceuticals Tizanidine 4mg Tablets Recall: Failed Stability Specifications
Preferred Pharmaceuticals recalls 4mg Tizanidine Hydrochloride tablets due to failed stability specifications. Products may degrade over time, posing risks to medication effectiveness. Check NDC codes and expiration dates for affected lots.
Lower-risk recall
Failed Stability Specifications
Contact the company
What happened, in plain English
Preferred Pharmaceuticals is recalling 4mg Tizanidine Hydrochloride tablets that failed stability tests. This means the medication might not work as intended over time, which could affect treatment effectiveness. Read more at govinfonow.com/recall/33399-preferred-pharmaceuticals-tizanidine-4mg-tablets-recall-failed-stability-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/33399-preferred-pharmaceuticals-tizanidine-4mg-tablets-recall-failed-stability-specifications · Updated September 23, 2026 · FDA enforcement record: FDA #D-0894-2023
Cite this page
“Preferred Pharmaceuticals Tizanidine 4mg Tablets Recall: Failed Stability Specifications.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33399-preferred-pharmaceuticals-tizanidine-4mg-tablets-recall-failed-stability-specifications. Based on FDA recall #D-0894-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0894-2023%22&limit=1).
Why it’s dangerous
The tablets failed stability specifications, meaning they may lose potency over time. This could lead to the medication not working properly when taken, potentially affecting treatment outcomes for conditions like spasticity.
Who’s affected
People who have the 4mg Tizanidine Hydrochloride tablets with specific NDC codes and expiration dates listed in the recall. Those taking this medication for conditions like spasticity are most at risk of ineffective treatment.
How to tell if you have this one
Check the NDC codes: 68788-7781-2 (20-count), 68788-7781-3 (30-count), 68788-7781-6 (60-count), 68788-7781-9 (90-count), or 68788-7781-8 (120-count). Also look for expiration dates of 12/31/2023 or earlier.
- Brand
Preferred Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Verify the NDC code and expiration date on your medication bottle to see if it matches the recalled items listed.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 16 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
Are there any safety risks from using this medication?
The recall is for potential reduced effectiveness, not immediate safety risks like injury or illness.
Similar recalls
Other Preferred Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0894-2023 (June 26, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0894-2023 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.